We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
93
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCHW
76
Charles Schwab
SCHW
$185B
| $184M | 0.25% |
2,521,869
-108,455
| -4% | -$7.75M |
|
77
Boeing
BA
$187B
| $181M | 0.25% |
824,945
-20,882
| -2% | -$4.66M |
|
78
S&P Global
SPGI
$123B
| $173M | 0.23% |
406,581
-7,029
| -2% | -$3.05M |
|
79
Zoetis
ZTS
$31.8B
| $173M | 0.23% |
888,860
-19,812
| -2% | -$4M |
|
80
Prologis
PLD
$131B
| $170M | 0.23% |
1,353,293
-13,670
| -1% | -$1.77M |
|
81
Booking.com
BKNG
$149B
| $165M | 0.22% |
1,739,400
-24,625
| -1% | -$2.21M |
|
82
Elevance Health
ELV
$82B
| $164M | 0.22% |
438,865
-10,202
| -2% | -$3.88M |
|
83
Deere & Co
DE
$166B
| $161M | 0.22% |
480,885
-14,853
| -3% | -$5.35M |
|
84
Caterpillar
CAT
$401B
| $159M | 0.22% |
829,392
-2,799
| -0.3% | -$583K |
|
85
Charter Communications
CHTR
$17.6B
| $157M | 0.21% |
215,771
-18,087
| -8% | -$13.7M |
|
|
86
Analog Devices
ADI
$183B
| $153M | 0.21% |
911,307
+274,607
| +43% | +$46.1M |
|
87
Automatic Data Processing
ADP
$106B
| $151M | 0.2% |
755,031
-25,022
| -3% | -$5.15M |
|
88
ConocoPhillips
COP
$144B
| $150M | 0.2% |
2,210,268
-93,360
| -4% | -$5.39M |
|
89
GE Aerospace
GE
$385B
| $147M | 0.2% |
2,296,885
-73,838
| -3% | -$4.75M |
|
90
Stryker
SYK
$128B
| $147M | 0.2% |
555,911
-1,941
| -0.3% | -$519K |
|
91
Mondelez International
MDLZ
$78.2B
| $146M | 0.2% |
2,513,945
+86,634
| +4% | +$5.39M |
|
92
Gilead Sciences
GILD
$162B
| $144M | 0.2% |
2,067,025
-66,949
| -3% | -$4.7M |
|
93
US Bancorp
USB
$100B
| $144M | 0.19% |
2,419,497
-108,896
| -4% | -$6.2M |
|
94
PNC Financial Services
PNC
$101B
| $142M | 0.19% |
725,224
-29,852
| -4% | -$5.64M |
|
95
Lam Research
LRCX
$388B
| $139M | 0.19% |
2,437,430
+107,100
| +5% | +$6.52M |
|
96
TJX Companies
TJX
$173B
| $136M | 0.18% |
2,055,199
-56,400
| -3% | -$3.94M |
|
|
MRSH
97
Marsh
MRSH
$91.1B
| $134M | 0.18% |
881,811
-42,852
| -5% | -$6.48M |
|
98
Crown Castle
CCI
$33.5B
| $133M | 0.18% |
768,340
-16,247
| -2% | -$3.14M |
|
99
Linde
LIN
$223B
| $133M | 0.18% |
452,917
+8,978
| +2% | +$2.73M |
|
100
Lockheed Martin
LMT
$135B
| $132M | 0.18% |
381,751
-4,755
| -1% | -$1.72M |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 93 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 93 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.